Bio-Rad Laboratories | BIO - Market Capitalization


Bio-Rad Laboratories reported $7.94B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 158.05B 20.36B Jun/2026
Agilent USD 32.66B 5.2B Mar/2026
Becton, Dickinson and Co. USD 44.77B 10.52B Mar/2026
Bio Techne USD 8.18B 987M Mar/2026
Bio-Rad Laboratories USD 7.56B 81M Aug/2026
Bruker USD 7.63B 1.54B Aug/2026
Charles River Laboratories USD 13.38B 2.98B Aug/2026
Danaher USD 138.86B 10.4B Jun/2026
General Electric Aerospace USD 389.93B 93.44B Jun/2026
Illumina USD 26.71B 8.84B Jun/2026
IQVIA Holdings USD 42.66B 10.41B Aug/2026
Laboratory Of America USD 22.96B 1.03B Jun/2026
Merck USD 324.18B 6.81B Aug/2026
Mettler Toledo International USD 25.82B 278M Jun/2026
OraSure Technologies USD 174M 61M Dec/2025
Pacific Biosciences Of California USD 565M 180M Dec/2025
Quest Diagnostics USD 23.46B 1.77B Jun/2026
Repligen USD 7.86B 168M Aug/2026
Revvity USD 13.76B 1.07B Aug/2026
Roche Holding CHF 270B 3.66B Jun/2026
Siemens EUR 160.86B 30.46B Mar/2026
Standard Biotools USD 359M 133M Mar/2026
Thermo Fisher Scientific USD 190.65B 7.99B Jun/2026
Tosoh JPY 844.69B 106.82B Aug/2026
Waters USD 23.45B 13.79B Aug/2026